+91-98 455 710 46 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
2 Jun 2015

Actavis acquires UK-based Auden Mckenzie

Actavis plc,  a specialty pharmaceutical company, has completed the acquisition of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK. Actavis acquired Auden Mckenzie for approximately £306 million in cash, plus a two-year royalty on a percentage of gross profits of one of Auden Mckenzie’s products.

The acquisition of Auden Mckenzie makes Actavis the number one supplier of generic pharmaceuticals in the UK and gives the company the number three position in the supply of UK pharmaceuticals.

“The acquisition of Auden Mckenzie is a strategic combination that makes Actavis the number one generic company in the UK and aligns with our strategy to establish a leading position in all of our markets, franchises and therapeutic categories,” said Brent Saunders, CEO and president of Actavis.

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests